The post Top 3 Gold Miner stocks to buy right now appeared on BitcoinEthereumNews.com. The gold mining sector has reasserted itself as one of 2025’s standout asset classes, propelled by U.S. fiscal policy shifts, geopolitical uncertainty, and record central bank demand. With President Donald Trump doubling down on tariffs and openly pressuring the Federal Reserve to cut rates, investors are increasingly turning to gold as a hedge against inflation, dollar weakness, and broader market volatility. The result has been a surge not just in bullion, but in the equities that track the sector. The NYSE Arca Gold Miners Index has gained over 50% year-to-date, easily outpacing gold’s own 25.3% rise.  Analysts argue that Wall Street is still underpricing the new reality, leaving room for earnings upgrades as higher gold prices flow through balance sheets. Gold Miners vs. Gold Price: Building on relative strength, it reached a new 52-week high on Friday. ⛏️🪙However, it is still trading at historically low levels, especially considering the record-breaking margins of leading gold producers.$GDX $GLD pic.twitter.com/r2LElJ7Gq7 — Oliver Groß (@minenergybiz) September 1, 2025 Several names stand out for their strong performance and leverage to the gold rally: Newmont Corp (NYSE: NEM) NEM shares have rallied to $74.40, up 93.9% year-to-date, as the world’s largest gold miner continues to benefit from scale, cost discipline, and exposure to rising bullion prices. NEM YTD stock price chart. Source: Finbold Royal Gold Inc (NASDAQ: RGLD)  Royal Gold was trading at $179.58, the royalty and streaming specialist is up 33.5% year-to-date. Its asset-light model provides exposure to higher gold prices with lower operating risks, making it a favored pick among institutional investors. RGLD YTD stock price chart. Source: Finbold Agnico Eagle Mines Ltd (NYSE: AEM)  Agnico Eagle Mines shares sit at $144.17, a gain of 75.8% year-to-date. The Canadian miner has expanded production capacity while keeping costs under control, positioning it as one of… The post Top 3 Gold Miner stocks to buy right now appeared on BitcoinEthereumNews.com. The gold mining sector has reasserted itself as one of 2025’s standout asset classes, propelled by U.S. fiscal policy shifts, geopolitical uncertainty, and record central bank demand. With President Donald Trump doubling down on tariffs and openly pressuring the Federal Reserve to cut rates, investors are increasingly turning to gold as a hedge against inflation, dollar weakness, and broader market volatility. The result has been a surge not just in bullion, but in the equities that track the sector. The NYSE Arca Gold Miners Index has gained over 50% year-to-date, easily outpacing gold’s own 25.3% rise.  Analysts argue that Wall Street is still underpricing the new reality, leaving room for earnings upgrades as higher gold prices flow through balance sheets. Gold Miners vs. Gold Price: Building on relative strength, it reached a new 52-week high on Friday. ⛏️🪙However, it is still trading at historically low levels, especially considering the record-breaking margins of leading gold producers.$GDX $GLD pic.twitter.com/r2LElJ7Gq7 — Oliver Groß (@minenergybiz) September 1, 2025 Several names stand out for their strong performance and leverage to the gold rally: Newmont Corp (NYSE: NEM) NEM shares have rallied to $74.40, up 93.9% year-to-date, as the world’s largest gold miner continues to benefit from scale, cost discipline, and exposure to rising bullion prices. NEM YTD stock price chart. Source: Finbold Royal Gold Inc (NASDAQ: RGLD)  Royal Gold was trading at $179.58, the royalty and streaming specialist is up 33.5% year-to-date. Its asset-light model provides exposure to higher gold prices with lower operating risks, making it a favored pick among institutional investors. RGLD YTD stock price chart. Source: Finbold Agnico Eagle Mines Ltd (NYSE: AEM)  Agnico Eagle Mines shares sit at $144.17, a gain of 75.8% year-to-date. The Canadian miner has expanded production capacity while keeping costs under control, positioning it as one of…

Top 3 Gold Miner stocks to buy right now

The gold mining sector has reasserted itself as one of 2025’s standout asset classes, propelled by U.S. fiscal policy shifts, geopolitical uncertainty, and record central bank demand.

With President Donald Trump doubling down on tariffs and openly pressuring the Federal Reserve to cut rates, investors are increasingly turning to gold as a hedge against inflation, dollar weakness, and broader market volatility.

The result has been a surge not just in bullion, but in the equities that track the sector. The NYSE Arca Gold Miners Index has gained over 50% year-to-date, easily outpacing gold’s own 25.3% rise. 

Analysts argue that Wall Street is still underpricing the new reality, leaving room for earnings upgrades as higher gold prices flow through balance sheets.

Several names stand out for their strong performance and leverage to the gold rally:

Newmont Corp (NYSE: NEM)

NEM shares have rallied to $74.40, up 93.9% year-to-date, as the world’s largest gold miner continues to benefit from scale, cost discipline, and exposure to rising bullion prices.

NEM YTD stock price chart. Source: Finbold

Royal Gold Inc (NASDAQ: RGLD) 

Royal Gold was trading at $179.58, the royalty and streaming specialist is up 33.5% year-to-date. Its asset-light model provides exposure to higher gold prices with lower operating risks, making it a favored pick among institutional investors.

RGLD YTD stock price chart. Source: Finbold

Agnico Eagle Mines Ltd (NYSE: AEM) 

Agnico Eagle Mines shares sit at $144.17, a gain of 75.8% year-to-date. The Canadian miner has expanded production capacity while keeping costs under control, positioning it as one of the sector’s most attractive growth stories.

AEM YTD stock price chart. Source: Finbold

While gold itself has delivered strong returns in 2025, miners are offering leveraged upside. With Trump-era fiscal and trade policies likely to extend volatility into 2026, analysts expect demand for gold equities to remain robust. For investors seeking exposure to the metal with amplified returns, the leading gold miners remain a compelling bet.

Source: https://finbold.com/top-3-gold-miner-stocks-to-buy-right-now/

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$5.343
$5.343$5.343
-1.65%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26